Yashaswi Dhiman: Advancing Hemovigilance Through Award-Winning Science
Yashaswi Dhiman, Associate Professor at Himalayan Institute of Medical Sciences , Swami Rama Himalayan University, shared a post on LinkedIn:
“Our 1st batch of TM residents , and we bag the BEST THESIS AWARD after a rigorous two round evaluation of thesis presentations from different specialities.
Our third year resident Dr Rolika Nautiyal did her thesis on ‘Active hemovigilance and clinical compliance evaluation to advise by a TM expert for preventing recurrences of Adverse transfusion reactions (ATRs)’.
It involved ATR workups and documented Reporting for diagnosis imputability and advice on preventing strategies .
These patients were actively followed up for repeat transfusions , ATR recurrences and Compliance .
Its moments like these we feel absolutely overwhelmed as mentors , guides and teachers and, we teach, treat , learn and grow to serve our purpose as doctors.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?